Business · 08/02/2007Updated: 10/17/2026 · 1 min read
FDA Reopens Comment Period for Human and Animal Drug Establishment Registration and Listing Rule
Summary
The FDA is extending the comment period for a proposed rule on human and animal drug establishment registration and listing until February 26, 2007, due to technical issues that prevented some individuals from submitting electronic comments on the original deadline of January 26, 2007.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →